Back to Search
Start Over
Long-Term Functional Outcomes Among Childhood Survivors of Cancer Who Have a History of Osteonecrosis.
- Source :
-
Physical therapy [Phys Ther] 2020 Mar 10; Vol. 100 (3), pp. 509-522. - Publication Year :
- 2020
-
Abstract
- Background: Glucocorticoids used to treat childhood leukemia and lymphoma can result in osteonecrosis, leading to physical dysfunction and pain. Improving survival rates warrants research into long-term outcomes among this population.<br />Objective: The objective of this study was to compare the physical function and quality of life (QOL) of survivors of childhood cancer who had an osteonecrosis history with that of survivors who had no osteonecrosis history and with that of people who were healthy (controls).<br />Design: This was a cross-sectional study.<br />Methods: This study included St Jude Lifetime Cohort Study participants who were ≥ 10 years from the diagnosis of childhood leukemia or lymphoma and ≥ 18 years old; 135 had osteonecrosis (52.5% men; mean age = 27.7 [SD = 6.08] years) and 1560 had no osteonecrosis history (52.4% men; mean age = 33.3 [SD = 8.54] years). This study also included 272 people who were from the community and who were healthy (community controls) (47.7% men; mean age = 35.1 [SD = 10.46] years). The participants completed functional assessments and questionnaires about QOL.<br />Results: Survivors with osteonecrosis scored lower than other survivors and controls for dorsiflexion strength (mean score = 16.50 [SD = 7.91] vs 24.17 [SD = 8.61] N·m/kg) and scored lower than controls for flexibility with the sit-and-reach test (20.61 [SD = 9.70] vs 23.96 [SD = 10.73] cm), function on the Physical Performance Test (mean score = 22.73 [SD = 2.05] vs 23.58 [SD = 0.88]), and mobility on the Timed "Up & Go" Test (5.66 [SD = 2.25] vs 5.12 [SD = 1.28] seconds). Survivors with hip osteonecrosis requiring surgery scored lower than survivors without osteonecrosis for dorsiflexion strength (13.75 [SD = 8.82] vs 18.48 [SD = 9.04] N·m/kg), flexibility (15.79 [SD = 8.93] vs 20.37 [SD = 10.14] cm), and endurance on the 6-minute walk test (523.50 [SD = 103.00] vs 572.10 [SD = 102.40] m).<br />Limitations: Because some eligible survivors declined to participate, possible selection bias was a limitation of this study.<br />Conclusions: Survivors of childhood leukemia and lymphoma with and without osteonecrosis demonstrated impaired physical performance and reported reduced QOL compared with controls, with those requiring surgery for osteonecrosis most at risk for impairments. It may be beneficial to provide strengthening, flexibility, and endurance interventions for patients who have pediatric cancer and osteonecrosis for long-term function.<br /> (© 2020 American Physical Therapy Association.)
- Subjects :
- Adolescent
Adult
Case-Control Studies
Child
Cross-Sectional Studies
Female
Glucocorticoids adverse effects
Humans
Male
Middle Aged
Muscle Strength
Osteonecrosis chemically induced
Osteonecrosis surgery
Range of Motion, Articular
Social Participation
Walk Test
Cancer Survivors
Leukemia drug therapy
Lymphoma drug therapy
Osteonecrosis physiopathology
Physical Functional Performance
Quality of Life
Subjects
Details
- Language :
- English
- ISSN :
- 1538-6724
- Volume :
- 100
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Physical therapy
- Publication Type :
- Academic Journal
- Accession number :
- 32044966
- Full Text :
- https://doi.org/10.1093/ptj/pzz176